间皮素作为癌症免疫治疗的生物标志物和治疗靶点
Mesothelin as Biomarker and Therapeutic Target for Immunotherapy in Cancer.
癌症仍是一个关键的全球健康问题,原因在于发现晚、耐药和高死亡率。
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Prognostic significance of CD8 and TCF1 double positive T cell subset in microsatellite unstable gastric cancer.
Prognostic significance of CD8 and TCF1 double positive T cell subset in microsatellite unstable gastric cancer.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
微卫星不稳定性高(MSI-H)胃癌(GC)具有较高的TIL(肿瘤浸润淋巴细胞)密度。尽管免疫微环境在MSI-H GC中的重要性已得到认可,我们对TIL的了解仍有限。
本研究旨在探讨T细胞亚群在MSI-H GC中的临床病理学及预后意义。研究对382份手术切除的MSI-H GC样本进行了CD8、TCF1和CD103单重免疫组化(IHC),以及CD8/TCF1和CD8/CD103双重IHC。定量分析单阳性或双阳性免疫细胞密度,并评估其与临床病理特征和总生存期(OS)的关系。TCF1+细胞密度与CD8+及CD103+细胞密度呈弱相关;CD8+/TCF1+细胞密度与CD8+/CD103+细胞密度呈中度相关(R²=0.539,p<0.001)。单重IHC分析显示,CD8+、TCF1+或CD103+细胞密度均与OS无显著关联(p>0.05)。
值得注意的是,CD8+/TCF1+细胞密度升高,以及CD8+/TCF1+细胞与CD8+细胞的比值较高,均与较不具侵袭性的临床病理特征和更佳OS相关(p分别为0.017和0.001)。多变量Cox回归分析确定,CD8+/TCF1+与CD8+细胞比值是独立预后因素(p=0.028)。
本研究在大型MSI-H GC队列中,利用双重IHC证实了CD8+/TCF1+与CD8+细胞比值的预后意义。
Microsatellite instability-high (MSI-H) gastric cancer (GC) exhibits high tumor-infiltrating lymphocyte (TIL) density. Despite the recognized significance of the immune microenvironment in MSI-H GC, our understanding of TIL remains limited.
This study aimed to investigate the clinicopathologic and prognostic implications of T cell subsets in MSI-H GC. Single immunohistochemistry (IHC) for CD8, TCF1, and CD103, and double IHC for CD8/TCF1 and CD8/CD103 were performed in 382 surgically resected MSI-H GC samples. Densities of single or double positive immune cells were quantified and correlated with clinicopathologic features and overall survival (OS).
TCF1 + cell densities showed weak correlations with CD8 + and CD103 + cell densities, while CD8+/TCF1 + cell density moderately correlated with CD8+/CD103 + cell density (R 2 = 0. 539, p < 0. 001). Single IHC analyses showed no significant associations between CD8+, TCF1+, or CD103 + cell densities and OS (p > 0. 05).
Notably, elevated CD8+/TCF1 + cell density and a high CD8+/TCF1 + to CD8 + ratio correlated with less aggressive clinicopathologic features and improved OS (p = 0. 017 and 0. 001, respectively). Multivariable Cox-regression identified CD8+/TCF1 + to CD8 + ratio as an independent prognostic factor (p = 0. 028).
We demonstrated the prognostic significance of CD8+/TCF1 + to CD8 + ratio using double IHC in a large cohort of MSI-H GC.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。